Clinical trial EVICTION
A fist-in-human, two-part, open-label, clinical study to assess the safety, tolerability and activity of intravenous doses of ICT01 as monotherapy and in combination with an Immune Checkpoint Inhibitor, in patients with advanced-stage, relapsed/refractory cancer
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Imcheck |
| EudraCT Identifier | 2019-003847-31 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04243499 |
| Inclusion criteria | Relasped/refractory patient |
| Last update |